Nephrology
News
Evidence Grows for SGLT2 Inhibitors in Rheumatology
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are not approved to treat gout, lupus, or lupus nephritis, but clinicians are uncovering signs...
News
Report: CKD Severity Linked to Thinning of Retina, Choroid Layers
The extent of this thinning predicts whether kidney function will decline going forward over a period of 2 or 3 years.
News
Children who are overweight at risk for chronic kidney disease
“Given the increasing obesity rates among adolescents, our findings are a harbinger of the potentially preventable increasing burden of CKD and...
News
Meet the newest acronym in primary care: CKM
“This approach not only raises awareness, it also empowers PCPs to diagnose and treat these conditions more holistically.”
News
Reducing albumin improves kidney and heart function in people with type 2 diabetes
A urine-to-creatinine ratio reduction of at least 30% reduced kidney risk by 64%.
News
Albuminuria reduction fuels finerenone’s kidney benefits
Mediation analyses of finerenone trial data show most of the drug’s kidney benefit and a third of its CVD benefit comes from cutting albuminuria...
News
T2D: Real benefits of new oral antidiabetic drugs
What about in the real world? Could combining SGLT2 inhibitors with GLP-1R agonists be even more effective?
Conference Coverage
Blood pressure lowering reduces dementia risk
“This proven, effective intervention should be widely scaled up to reduce the global burden of dementia.”
News
Risk calculator for early-stage CKD may soon enter U.S. market
Klinrisk, which estimates an adult’s risk for CKD progression from 20 lab values, may spur more targeted, intensified treatment.
Conference Coverage
Aprocitentan reduces resistant hypertension in CKD
Aprocitentan, a novel dual endothelin antagonist, showed antihypertensive efficacy and manageable safety in people with chronic kidney disease.